Labcorp (LH) financials
Labcorp revenue and earnings by year
Labcorp's revenue was $14.0 billion in the fiscal year to December 31, 2025, up 7.2% from the year before. Net income was $877 million, 6.3% of revenue. Since the fiscal year to December 31, 2016, revenue has grown 4.3% a year on average.
Fiscal years, each labelled by the calendar year it ended in.
Income statement, the last 10 fiscal years
| Fiscal year to | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 14.0 | 13.0 | 12.2 | 11.9 | 13.1 | 14.0 | 11.6 | 11.3 | 10.3 | 9.6 |
| Revenue growth | 7.2% | 7.0% | 2.5% | -9.7% | -6.0% | 21.0% | 2.0% | 9.9% | 7.9% | — |
| Gross profit | 4.0 | 3.6 | 3.4 | 3.7 | 5.0 | 5.0 | 3.3 | 3.2 | 3.1 | 2.9 |
| Gross margin | 28.8% | 27.9% | 27.7% | 31.3% | 38.0% | 35.4% | 28.1% | 28.0% | 30.0% | 29.9% |
| Operating income | 1.4 | 1.1 | 0.7 | 1.4 | 3.0 | 2.4 | 1.3 | 1.3 | 1.3 | 1.3 |
| Operating margin | 9.9% | 8.4% | 6.0% | 12.1% | 23.2% | 17.5% | 11.5% | 11.7% | 12.7% | 13.3% |
| Net income | 0.9 | 0.7 | 0.4 | 1.3 | 2.4 | 1.6 | 0.8 | 0.9 | 1.2 | 0.7 |
| Net margin | 6.3% | 5.7% | 3.4% | 10.8% | 18.1% | 11.1% | 7.1% | 7.8% | 11.9% | 7.5% |
| Diluted EPS | $10.46 | $8.84 | $4.77 | $12.00 | $20.95 | $13.64 | $7.18 | $7.39 | $10.15 | $6.01 |
| Free cash flow | 1.2 | 1.1 | 0.9 | 1.5 | 2.7 | 1.8 | 1.0 | 0.9 | 1.2 | 0.9 |
Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open LH in Markets.
How Labcorp makes money
Revenue by segment in the quarter to September 30, 2026, as the company reports it.
| Segment | Revenue | Share |
|---|---|---|
| Diagnostics | $2.95B | 77.3% |
| Biopharma Laboratory Services | $867M | 22.7% |
See also: LH valuation and P/E history · LH returns
No forecast, no recommendation. This page describes Labcorp from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.